Trials / Completed
CompletedNCT05289440
Esketamine Administration on Recovery Quality After Radical Mastectomy
The Effect of Esketamine on the Quality of Recovery After Modified Radical Mastectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Anqing Municipal Hospital · Academic / Other
- Sex
- Female
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Some studies have reported that intravenous esketamine reduce postoperative pain intensity. The investigators investigated whether esketamine could improve the the quality of recovery after modified radical mastectomy.
Detailed description
A total of 111 patients were randomly allocated into 3 groups. Patients in group LE received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 2 µg/kg/min until before suture the skin. Patients in group HE received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 4 µg/kg/min until before suture the skin. Patients in group CON received a bolus infusion of the same volume saline before cutting the skin, and then the same volume saline was infused until before suture the skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low-dose esketamine infusion | Patients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 2 µg/kg/min until before suture the skin. |
| DRUG | High-dose esketamine infusion | Patients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 4 µg/kg/min until before suture the skin. |
| DRUG | Saline infusion | Patients received a bolus infusion of the same volume saline before cutting the skin, and then the same volume saline was infused until before suture the skin. |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2022-09-15
- Completion
- 2022-09-20
- First posted
- 2022-03-21
- Last updated
- 2022-11-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05289440. Inclusion in this directory is not an endorsement.